ATDBio is a UK-based life sciences company specialising in the synthesis and supply of oligonucleotides for research, diagnostics, and therapeutic development. With extensive expertise in nucleic acid chemistry and advanced manufacturing capabilities, we produce high-quality, customised DNA and RNA oligonucleotides for customers across academia, biotechnology, and the pharmaceutical industry.

Our oligonucleotides support a wide range of applications, including molecular diagnostics, next-generation sequencing, drug discovery and proteomics. ATDBio is particularly recognised for its ability to manufacture highly modified and technically challenging oligonucleotides, helping scientists and organisations accelerate innovation in genetics and precision medicine.

Founded in 2005 and headquartered in the United Kingdom, ATDBio is part of the Biotage Group, expanding global access to specialised oligonucleotide technologies and services.

Our mission is to enable breakthroughs in life science by providing reliable, high-purity oligonucleotides and expert technical support to researchers and biotechnology companies worldwide.

ATDBio

Org chart

Teams

Offices